Familial chylomicronemia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:444490OMIM:145750E78.3
Who is this for?
Show terms as
2FDA treatments1Active trials34Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial chylomicronemia syndrome (FCS), also called lipoprotein lipase deficiency or type I hyperlipoproteinemia, is a rare inherited condition where the body cannot properly break down fats in the blood. Normally, an enzyme called lipoprotein lipase (LPL) clears fatty particles called chylomicrons from the bloodstream after meals. In FCS, this process is severely impaired, causing triglyceride levels to build up to dangerously high levels — often 10 to 100 times above normal. This fat buildup can cause repeated episodes of severe abdominal pain, inflammation of the pancreas (called pancreatitis), and a range of other symptoms. Pancreatitis attacks can be life-threatening and may happen without warning, often triggered by eating fatty foods, drinking alcohol, or even stress. Over time, repeated attacks can permanently damage the pancreas. Managing FCS centers on an extremely low-fat diet — typically less than 10 to 15 grams of fat per day — which is very restrictive and difficult to maintain. A newer FDA-approved medication called volanesorsen (brand name Waylivra) is available in some countries to help lower triglyceride levels. While FCS is not curable, careful management can reduce the risk of dangerous complications and improve quality of life.

Key symptoms:

Severe stomach pain, often in the upper abdomenRepeated episodes of pancreatitis (inflammation of the pancreas)Nausea and vomitingCreamy or milky appearance of blood (lipemia)Yellowish fatty deposits under the skin called xanthomasEnlarged liver or spleenFatigue and general feeling of being unwellMemory problems or difficulty concentrating (brain fog)Anxiety and depression related to dietary restrictions and unpredictable attacksPale, fatty stoolsLoss of appetite

Clinical phenotype terms (22)— hover any for plain English
Increased circulating chylomicron concentrationHP:0012238Lipemia retinalisHP:0000660Acute pancreatitisHP:0001735Recurrent pancreatitisHP:0100027Eruptive xanthomasHP:0001013Pulmonary embolismHP:0002204Perianal abscessHP:0009789
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Dec 2024

Tryngolza: FDA approved

adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS)

FDAcompleted
Sep 2024Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

Ikaria Bioscience Pty Ltd — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

Redemplo

plozasiran· Arrowhead Pharmaceuticals, Inc.Orphan Drug

as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS)

Tryngolza

olezarsen· Ionis PharmaceuticalsOrphan Drug

adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS)

Clinical Trials

1 recruitingView all trials with filters →

Specialists

Showing 25 of 34View all specialists →
ST
Sotirios Tsimikas
SAN DIEGO, CA
Specialist
6 Familial chylomicronemia syndrome publications
RH
Robert A Hegele
Specialist
10 Familial chylomicronemia syndrome publications
VA
Veronica J Alexander
Specialist
7 Familial chylomicronemia syndrome publications
DG
Daniel Gaudet
Specialist
7 Familial chylomicronemia syndrome publications
MA
Marcello Arca
Specialist
5 Familial chylomicronemia syndrome publications
EK
Ewa Karwatowska-Prokopczuk
Specialist
4 Familial chylomicronemia syndrome publications
HS
Handrean Soran
Specialist
4 Familial chylomicronemia syndrome publications
SX
Shuting Xia
Specialist
4 Familial chylomicronemia syndrome publications
JW
Joseph L Witztum
SAN DIEGO, CA
Specialist
4 Familial chylomicronemia syndrome publications
JW
Jian Wang
Specialist
4 Familial chylomicronemia syndrome publications
PV
Pedro Valdivielso
Specialist
4 Familial chylomicronemia syndrome publications
HG
Henry N Ginsberg
WEST HEMPSTEAD, NY
Specialist
3 Familial chylomicronemia syndrome publications
ES
Erik S G Stroes
Specialist
2 Familial chylomicronemia syndrome publications
YL
YALIANG LI
Specialist
PI on 2 active trials1783 Familial chylomicronemia syndrome publications
JN
Juan Patricio Nogueira
HACKENSACK, NJ
Specialist
4 Familial chylomicronemia syndrome publications
MV
Montserrat Vera-Llonch
Specialist
3 Familial chylomicronemia syndrome publications
ZA
Zahid Ahmad
DALLAS, TX
Specialist
2 Familial chylomicronemia syndrome publications
DY
Dong YOU
Specialist
PI on 1 active trial
AB
Archna Bajaj
PHILADELPHIA, PA
Specialist
3 Familial chylomicronemia syndrome publications
CB
Christie M Ballantyne
HOUSTON, TX
Specialist
3 Familial chylomicronemia syndrome publications
IG
Ioanna Gouni-Berthold
Specialist
2 Familial chylomicronemia syndrome publications
MI
Maria Cristina Izar
AKRON, OH
Specialist
2 Familial chylomicronemia syndrome publications
RO
Ron
NY
Specialist
2 Familial chylomicronemia syndrome publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial chylomicronemia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial chylomicronemia syndromeForum →

No community posts yet. Be the first to share your experience with Familial chylomicronemia syndrome.

Start the conversation →

Latest news about Familial chylomicronemia syndrome

No recent news articles for Familial chylomicronemia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is my exact genetic mutation, and what does it mean for my treatment options?,How low does my fat intake need to be, and can a dietitian help me create a realistic meal plan?,Am I a candidate for volanesorsen or any other newer medications?,What should I do if I think I am having a pancreatitis attack — when should I go to the emergency room?,Should my family members be tested for this condition?,Are there any clinical trials I might be eligible for?,How often do I need blood tests and specialist check-ups to monitor my condition?

Common questions about Familial chylomicronemia syndrome

What is Familial chylomicronemia syndrome?

Familial chylomicronemia syndrome (FCS), also called lipoprotein lipase deficiency or type I hyperlipoproteinemia, is a rare inherited condition where the body cannot properly break down fats in the blood. Normally, an enzyme called lipoprotein lipase (LPL) clears fatty particles called chylomicrons from the bloodstream after meals. In FCS, this process is severely impaired, causing triglyceride levels to build up to dangerously high levels — often 10 to 100 times above normal. This fat buildup can cause repeated episodes of severe abdominal pain, inflammation of the pancreas (called pancreat

How is Familial chylomicronemia syndrome inherited?

Familial chylomicronemia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Familial chylomicronemia syndrome?

Yes — 1 recruiting clinical trial is currently listed for Familial chylomicronemia syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Familial chylomicronemia syndrome?

25 specialists and care centers treating Familial chylomicronemia syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Familial chylomicronemia syndrome?

2 patient support programs are currently tracked on UniteRare for Familial chylomicronemia syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.